CJC-1295 + IPA 10MG

CJC-1295 (No DAC) + Ipamorelin is a complementary research blend combining a growth hormone-releasing hormone analogue with a selective growth hormone secretagogue. CJC-1295 (No DAC) is studied for GHRH-receptor signalling, while Ipamorelin is explored for selective activation of the ghrelin receptor pathway.

Together, the two peptides provide researchers with a dual-pathway model for examining pulsatile growth-hormone signalling, endocrine feedback, protein-synthesis pathways, lipid utilization and metabolic regulation. The balanced 5 mg + 5 mg format supports controlled comparative research.

Choice Peptides CJC-1295 (No DAC) + Ipamorelin is supplied as a high-purity lyophilized blend and meticulously tested for identity, purity and consistency.

Form: Lyophilized peptide blend
Contents: CJC-1295 (No DAC) 5 mg + Ipamorelin 5 mg
Purity: ≥99%
Testing: Meticulously tested for identity, purity and consistency
Storage: Keep in a cool, dry environment; refrigerate at 2°C–8°C after reconstitution
Intended use: For laboratory research purposes only. Not for human or veterinary use.